Revision Ventriculoperitoneal shunts in children: Clinical profile and outcomes”
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2023 - 65535
Project Lead
Dr. Shubha AM
Authors
Dr. Shubha AM, Dr. Rajkiran Raju S, Dr. Aaron Vincent Lyngdoh(MBBS) and Dr.Steevan Sebastian(MBBS)
Project Status
completed